IndraLab

Statements


Modified beta-amyloid peptide increases the amount of SCN1A. 1 / 1
| 1

reach
"An interesting example is the finding that overexpression of beta-amyloid peptide, the pathogenic amyloid forming fragment in Alzheimer 's disease, drives down Scn1a expression in cortical interneurons 43."